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We report  the  approach  to  a  29  year  old  patient  presenting  with  the  diagnosis  of a Budd-Chiari  Syndrome,
with  clinical  deterioration  after  initial anticoagulation  treatment.
The patient  was proposed  to endovascular  treatment.
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Through intra-hepatic  shunting  seen  at angiography,  and  from  a  left  to right liver lobe,  a  guide-wire
was  passed  retrogadely  and  allowed  sufﬁcient  support  to perform  hepatic  vein  angioplasty  and  stenting.
The  patient  responded  favourably  and  liver  transplant  was  avoided.
©  2016  Published  by Elsevier  Ltd.  This  is an  open  access  article  under the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).nterventional radiology
. Introduction
The authors report a case of endovascular treatment of a Budd-
hiari syndrome, with recanalization and stent placement in an
ccessory right lower hepatic vein by a collateral loop-guided
pproach through a left-lobe partially patent hepatic vein.
. Clinical history
A 29 year old patient, under hypocoagulation due to anty-
hospholypid syndrome with two previous cases of deep vein
hrombosis, recurred to emergency room. The patient had recently
hanged to a different type of dicumarinic treatment. She pre-
ented with acute abdominal pain, malaise, increase in abdominal
irth. The patient was alert, oriented and cooperative. On inspec-
ion, the patient appeared icteric and a palpable liver was  felt
ellow the costal margins. Blood analysis revealed increased in liver
nzymes, with a predominant hepatocellular changes (aspartate
minotransferase (AST) and alanineaminotrasnferase (ALT) were
38 U/L and 82 U/L respectively, an increase of 4.6-fold and 2.3-fold
espectively). Billirubin levels were also increased (total billirru-
in of 4.02 mg/dL, with a direct level of 2.43 mg/dL). INR levels
ere 2,7. The patient presented also leucocytosis (12.3 × 109ˆ/L) and
ncreased C-reactive protein levels (233). Abdominal ultrasound
evealed the existence of ascites, increased liver size. Abdominal
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352-0477/© 2016 Published by Elsevier Ltd. This is an open access article under the CC BCT showed additionally that the liver enhanced heterogeneously,
with permeable inferior vena casa and absence of opaciﬁcation of
the hepatic veins.
The patient was diagnosed with a Budd-Chiari Syndrome. Deci-
sion between TIPS, liver transplant or continue hypocoagulation
and support treatment pended toward continuing hypocoagulation
with enoxaparin as the patient presented no signs of encephalopa-
thy, and withholding dicumarinics as these made unable to assess
liver function through Prothrombin time and INR at this time.
On follow-up, the patient had further increase in liver function
test (AST and ALT were 539U/L and 220 U/L respectively, mean-
ing an increase of 18-fold and 6.2-fold respectively from normal);
bilirubin levels increased (total billirrubin of 8.80 mg/dL with a
direct level 7.60 mg/dL), as did the INR levels (INR = 4.45). Leucocy-
tosis further increased (20 × 109ˆ/L) as did C-reactive protein (297).
The patient was  discussed for endovascular treatment, and the pos-
sibility of a TIPS was considered, with liver transplantation as a ﬁnal
treatment option.
She was  referred to our institution for emergent endovascular
treatment.
Procedure planning and execution
On procedure planning, TIPS presented some problems in this
speciﬁc patient. Firstly, despite leucocytosis, increased PCR and
mild fever could be explained by the liver failure, an occult infective
focus should be considered (empiric treatment with amoxicil and
clavulanate was started). Secondly, the reported incidence of tran-
shepatic puncture in TIPS is stated to be about 33% [1], a risk to be
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. (A) left lobe venography showing a permeable left hepatic vein (slim arrow), with intrahepatic collaterals (arrowhead). (B) continuing injection of contraste shows that
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uring injection. (C) Nitinol guidewire passed through from the left to right lower 
ndicates deployed stent in the previously stenotic hepatic vein conﬂuence.
onsidered in a patient with clearly abnormal coagulation status.
inally, from a technical standpoint, hepatic vein catheterization
ight be difﬁcult due to the thrombus and distorted anatomy.
Procedure objectives were evaluation and possibly recanaliza-
ion of the hepatic veins.
Vascular access was obtained through the right jugular vein with
 11 cm 6F introducer (Boston Scientiﬁc, Natick, Massachusetts).
A nitinol hydrophilic 0.035′ (Terumo®) guidewire was passed
etrogadely to the main left hepatic, the only one amenable of vas-
ular catheterization despite the stenosis at its conﬂuence with
nferior vena cava, followed by a 4F Cobra catheter. Pre-procedure
occluded” hepatic vein pressure was measured at 27 mmHg.
Reverse portography was performed, with opaciﬁcation of intra-
epatic shunts. (Fig. 1A). A guidewire was progressed through
ntrahepatic shunts from the left to the right lobe where a variant
ouble right hepatic vein was seen. (Fig. 1B) Despite the occluding
hrombosis, it was possible to pass a guidewire retrogadely to the
nferior vena cava by the lower right hepatic vein (Fig. 1C).
A second right jugular access was established (7F sheath)
hrough which a “snare” was used to retrieve the ﬂoppy ending of
he hydrophilic guidewire, previously passed through to the infe-
ior vena cava
A 65 cm 4F multipurpose catheter (Cook®) was  introduced
hrough the “ﬂoppy” ending of the wire and into the right lower
epatic vein.
After this, the hydrophilic guidewire was pulled out of the
atheter, by pulling from the “stiff” ending, and the catheter wasepatic vein (fat arrowhead). Dotted line shows the orientation of the oppaciﬁcation
ic vein. Arrowheads in dotted line shows the path taken by the wire. (D) fat arrow
used for passing a 180 cm Amplatz Super Stiff TM (Boston Scientiﬁc
TM) through the second vascular access and into the right lower
hepatic vein. This allowed sufﬁcient support for placing two stent
(14 × 40 mm,  Zilverﬂex Cook®). (Fig. 1D) Baloon angioplasty was
also performed on the left hepatic vein at the convergence with the
inferior vena cava. After this, “occlusion” hepatic vein pressure was
measured 10 mmHg.
The patient was  transferred to an intensive care unit. She devel-
oped a right neck hematoma, with no further complications, having
had been discharged after liver function and bleeding diathesis had
been normalized. She resumed the previously prescribed anticoag-
ulation regimen and liver transplantation was  not required.
3. Discussion
Endovascular recanalization of the hepatic veins is usually per-
formed by either balloon dilation or stent placement, with stent
placement reducing the restenosis rate [2].
Results of endovascular “suprahepatic” venous obstruction have
been good, potentially stopping liver damage caused by portal
hypertension and preventing liver transplantation [3].
Antegrade percutaneous approaches are theoretically possible
and have been described with success. However, unwanted compli-
cations are to be accounted for, as these patients typically present
with decompensated liver failure, bleeding diathesis and risk suf-
fering from serious life threatening intra-peritoneal bleeding [4].
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Previously a retrograde hepatic vein angioplasty using a similar
ollateral loop-guided approach was reported, passing a guide wire
hrough the caudate lobe, through intrahepatic collaterals, and out
hrough another main hepatic vein in the same lobe, establishing
n “intra-hepatic loop” [5].
TIPS remains an adequate alternative treatment to Chiari Syn-
rome. Unwanted problems correspond to possible liver capsule
erforation, and the presence of a possible infectious at the time
he procedure was considered necessary.
In this letter, we present another endovascular recanalization
nd stent placement in the hepatic veins. The main difference was
hat the only amenable venous access to the liver was through
he left liver lobe, which allowed passing a guide wire through
ntrahepatic collaterals to the right liver lobe. To our knowledge,
ollateral loop-guided approach from the left to the right lobe
adn’t been previously reported.
Hepatic “occlusion” pressure, representing portal hypertension,lso decreased signiﬁcatively.
Despite the ominous prognostic, the patient responded well
o therapy, having been discharged, resuming the previous treat-
ents, with no major complications.
[of Radiology Open 3 (2016) 251–253 253
In summary, this report presents a case of right hepatic vein
angioplasty, successfully performed by a left lobe loop guided
approach, achieved through collateral venous shunts.
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